Tumor-associated macrophages: from mechanisms to therapy.

[1]  T. Rohan,et al.  Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer. , 2014, Journal of the National Cancer Institute.

[2]  J. Blay,et al.  Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. , 2014, Cancer cell.

[3]  X. Mo,et al.  Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer , 2014, PloS one.

[4]  J. Pollard,et al.  Myeloid WNT7b mediates the angiogenic switch and metastasis in breast cancer. , 2014, Cancer research.

[5]  Will Liao,et al.  The cellular and molecular origin of tumor-associated macrophages , 2014, Science.

[6]  K. Matsushima,et al.  Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes , 2014, Proceedings of the National Academy of Sciences.

[7]  H. Yao,et al.  A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. , 2014, Cancer cell.

[8]  P. Dessen,et al.  PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation , 2014, The Journal of experimental medicine.

[9]  G. Garlet,et al.  PD-1 blockage delays murine squamous cell carcinoma development. , 2014, Carcinogenesis.

[10]  Yibin Kang,et al.  Targeting tumor-stromal interactions in bone metastasis. , 2014, Pharmacology & therapeutics.

[11]  J. Wolchok,et al.  Immune modulation in cancer with antibodies. , 2014, Annual review of medicine.

[12]  K. Pienta,et al.  A multi-targeted approach to treating bone metastases , 2014, Cancer and Metastasis Reviews.

[13]  S. Weiss,et al.  Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells , 2013, Nature Neuroscience.

[14]  L. Coussens,et al.  CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells , 2013, Oncoimmunology.

[15]  G. Freeman,et al.  Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer. , 2013, Cancer research.

[16]  K. Schäkel,et al.  Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy. , 2013, Cancer cell.

[17]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .

[18]  Ming O. Li,et al.  TGF-β: Guardian of T Cell Function , 2013, The Journal of Immunology.

[19]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[20]  H. Schreiber,et al.  Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.

[21]  C. Hudis,et al.  Molecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer , 2013, Clinical Cancer Research.

[22]  B. Necela,et al.  Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs , 2013, The Journal of cell biology.

[23]  Hiroyoshi Nishikawa,et al.  Natural and Induced T Regulatory Cells in Cancer , 2013, Front. Immunol..

[24]  D. Wraith,et al.  Regulation of Adaptive Immunity; The Role of Interleukin-10 , 2013, Front. Immunol..

[25]  P. Allavena,et al.  Tumor-associated macrophages: functional diversity, clinical significance, and open questions , 2013, Seminars in Immunopathology.

[26]  David E. Anderson,et al.  Tumor-Associated Macrophages in Glioma: Friend or Foe? , 2013, Journal of oncology.

[27]  Thomas A. Wynn,et al.  Macrophage biology in development, homeostasis and disease , 2013, Nature.

[28]  R. Kaur,et al.  Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages , 2013, Clinical Cancer Research.

[29]  R. Muschel,et al.  VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice. , 2013, Blood.

[30]  C. Jobin.  Colorectal cancer: looking for answers in the microbiota. , 2013, Cancer discovery.

[31]  L. Coussens.  Neutralizing tumor-promoting chronic inflammation: A magic bullet? (Science (286)) , 2013 .

[32]  C. Lewis,et al.  Macrophage regulation of tumor responses to anticancer therapies. , 2013, Cancer cell.

[33]  M. Zucchetti,et al.  Role of macrophage targeting in the antitumor activity of trabectedin. , 2013, Cancer cell.

[34]  Jonathan B. Mitchem,et al.  Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. , 2013, Cancer research.

[35]  Chang-Yun Lin,et al.  The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma , 2013, Molecular oncology.

[36]  J. Gribben,et al.  The role of B7 family molecules in hematologic malignancy. , 2013, Blood.

[37]  A. Palucka,et al.  Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.

[38]  A. Cerwenka,et al.  Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth , 2012, The Journal of Immunology.

[39]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[40]  Sofia Depner,et al.  Vascular endothelial growth factor‐induced skin carcinogenesis depends on recruitment and alternative activation of macrophages , 2012, The Journal of pathology.

[41]  Yu Shen,et al.  Increase of Circulating B7-H4–Expressing CD68+ Macrophage Correlated With Clinical Stage of Lung Carcinomas , 2012, Journal of immunotherapy.

[42]  Lei Zhao,et al.  Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. , 2012, Blood.

[43]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[44]  Mikala Egeblad,et al.  Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells. , 2012, Cancer cell.

[45]  S. Rafii,et al.  Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. , 2012, Cancer research.

[46]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[47]  A. Mantovani,et al.  Cancer-related inflammation: common themes and therapeutic opportunities. , 2012, Seminars in cancer biology.

[48]  C. Kyriakopoulos,et al.  Myeloid-derived Suppressor Cells in Cancer Patients: A Clinical Perspective , 2012, Journal of immunotherapy.

[49]  Daniel G. Anderson,et al.  Origins of tumor-associated macrophages and neutrophils , 2012, Proceedings of the National Academy of Sciences.

[50]  R. Schwendener,et al.  Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors , 2012, BMC Cancer.

[51]  A. Hayday,et al.  Langerhans Cells Facilitate Epithelial DNA Damage and Squamous Cell Carcinoma , 2012, Science.

[52]  P. De Baetselier,et al.  Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. , 2011, The International journal of developmental biology.

[53]  J. Massagué,et al.  Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. , 2011, Cancer cell.

[54]  L. Su,et al.  Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. , 2011, Cancer research.

[55]  T. Wynn,et al.  Regulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase , 2011, The Journal of Immunology.

[56]  Laura J. Esserman,et al.  Leukocyte composition of human breast cancer , 2011, Proceedings of the National Academy of Sciences.

[57]  Michele De Palma,et al.  The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. , 2011, The International journal of developmental biology.

[58]  Jinghang Zhang,et al.  CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.

[59]  Karin Jirström,et al.  Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. , 2011, Cancer discovery.

[60]  C. Di Serio,et al.  TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. , 2011, The Journal of clinical investigation.

[61]  L. Naldini,et al.  Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. , 2011, Cancer cell.

[62]  D. Lyden,et al.  The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. , 2011, Seminars in cancer biology.

[63]  Hong Wang,et al.  Tumor-Associated Macrophages Recruit CCR6+ Regulatory T Cells and Promote the Development of Colorectal Cancer via Enhancing CCL20 Production in Mice , 2011, PloS one.

[64]  L. Coussens,et al.  Leukocytes in mammary development and cancer. , 2011, Cold Spring Harbor perspectives in biology.

[65]  H. Saito,et al.  Increased B7-H1 and B7-H4 Expressions on Circulating Monocytes and Tumor-Associated Macrophages are Involved in Immune Evasion in Patients with Gastric Cancer , 2011, Yonago acta medica.

[66]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[67]  L. Coussens,et al.  Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. , 2010, Cancer research.

[68]  P. De Baetselier,et al.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.

[69]  M. Aoki,et al.  Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model , 2010, Proceedings of the National Academy of Sciences.

[70]  W. Pao,et al.  Tumorigenesis and Neoplastic Progression Tumor Progression Stage and Anatomical Site Regulate Tumor-Associated Macrophage and Bone Marrow-Derived Monocyte Polarization , 2010 .

[71]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[72]  M. Smrčka,et al.  Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: A role in innate immunity? , 2010, Journal of Neuroimmunology.

[73]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[74]  A. Lusis,et al.  Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. , 2010, Blood.

[75]  Andrew V. Nguyen,et al.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. , 2010, The American journal of pathology.

[76]  J. Joyce,et al.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. , 2010, Genes & development.

[77]  T. Lucas,et al.  Stromal cell‐derived CSF‐1 blockade prolongs xenograft survival of CSF‐1‐negative neuroblastoma , 2009, International journal of cancer.

[78]  Ruth J. Muschel,et al.  A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth , 2009, PloS one.

[79]  L. Coussens,et al.  CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. , 2009, Cancer cell.

[80]  Russell Hughes,et al.  Tumor-associated macrophages: effectors of angiogenesis and tumor progression. , 2009, Biochimica et biophysica acta.

[81]  Jing Xu,et al.  Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 , 2009, The Journal of experimental medicine.

[82]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[83]  Bethan Psaila,et al.  The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.

[84]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[85]  M. Colombo,et al.  Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. , 2008, Cancer research.

[86]  P. Allavena,et al.  Macrophage polarization in tumour progression. , 2008, Seminars in cancer biology.

[87]  T. Ottenhoff,et al.  Human Anti-Inflammatory Macrophages Induce Foxp3+GITR+CD25+ Regulatory T Cells, Which Suppress via Membrane-Bound TGFβ-11 , 2008, The Journal of Immunology.

[88]  C. Sturgeon,et al.  A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[89]  S. Vandenberg,et al.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.

[90]  D. Carbone,et al.  Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.

[91]  F. Peale,et al.  Bv8 regulates myeloid-cell-dependent tumour angiogenesis , 2007, Nature.

[92]  J. Pollard,et al.  Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages , 2007, Molecular oncology.

[93]  B. Pulendran,et al.  Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17–producing T cell responses , 2007, Nature Immunology.

[94]  G. Freeman,et al.  Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. , 2007, Immunity.

[95]  S. Ferrone,et al.  Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release. , 2007, Cancer research.

[96]  J. Pollard,et al.  Tumor-associated macrophages press the angiogenic switch in breast cancer. , 2007, Cancer research.

[97]  N. Minato,et al.  SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion , 2007, Nature Genetics.

[98]  Yarong Wang,et al.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.

[99]  E. Carosella,et al.  Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. , 2006, Blood.

[100]  M. Willart,et al.  Contribution of the PD‐1 ligands/PD‐1 signaling pathway to dendritic cell‐mediated CD4+ T cell activation , 2006, European journal of immunology.

[101]  Gefeng Zhu,et al.  B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma , 2006, The Journal of experimental medicine.

[102]  A. Sica,et al.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). , 2006, Blood.

[103]  M. Colombo,et al.  Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. , 2006, Cancer research.

[104]  E. Stanley,et al.  Colony-stimulating factor-1 in immunity and inflammation. , 2006, Current opinion in immunology.

[105]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[106]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[107]  Lieping Chen,et al.  Expression of Functional B7-H2 and B7.2 Costimulatory Molecules and Their Prognostic Implications in De novo Acute Myeloid Leukemia , 2005, Clinical Cancer Research.

[108]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[109]  M. Colonna,et al.  Recombinant HLA‐G5 and ‐G6 drive U937 myelomonocytic cell production of TGF‐β1 , 2004, Journal of leukocyte biology.

[110]  B. Baban,et al.  Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase. , 2004, International immunology.

[111]  J. Trowsdale,et al.  The LILR family: modulators of innate and adaptive immune pathways in health and disease. , 2004, Tissue antigens.

[112]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[113]  J. Brayer,et al.  Arginase I Production in the Tumor Microenvironment by Mature Myeloid Cells Inhibits T-Cell Receptor Expression and Antigen-Specific T-Cell Responses , 2004, Cancer Research.

[114]  J. Dausset,et al.  HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[115]  Steven R Tannenbaum,et al.  Reactive nitrogen species in the chemical biology of inflammation. , 2004, Archives of biochemistry and biophysics.

[116]  J. Ochoa,et al.  l-Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes1 , 2003, The Journal of Immunology.

[117]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[118]  P. Loke,et al.  PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[119]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[120]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[121]  A. Sharpe,et al.  Negative co-receptors on lymphocytes. , 2002, Current opinion in immunology.

[122]  Andrew V. Nguyen,et al.  The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.

[123]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[124]  J. Coligan,et al.  Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis , 1998, The Journal of experimental medicine.

[125]  H. Reiser,et al.  Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages. , 1994, Journal of immunology.

[126]  P. Linsley,et al.  IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. , 1993, Journal of immunology.

[127]  J. Pollard,et al.  Breast Cancer Myeloid WNT 7 b Mediates the Angiogenic Switch and Metastasis in Updated , 2014 .

[128]  Clotilde Théry,et al.  CD8+ tumor-infiltrating T cells are trapped in the tumor-dendritic cell network. , 2013, Neoplasia.

[129]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[130]  Charles D Mills,et al.  M1 and M2 Macrophages: Oracles of Health and Disease. , 2012, Critical reviews in immunology.

[131]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[132]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[133]  M. Smyth,et al.  Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection , 2002, Nature Immunology.

[134]  I. Fidler.  Macrophage therapy of cancer metastasis. , 1988, Ciba Foundation symposium.